By: IPP Bureau
Last updated : September 29, 2026 8:28 am
There were no data integrity related observations
Zydus informed that the USFDA conducted cGMP inspection for the company’s manufacturing plant at SEZ II, Ahmedabad. The inspection was conducted from 21st to 28th September 2026.
The inspection closed with one observation. There were no data integrity related observations. The company will closely work with the USFDA to address the observation expeditiously.